Phase II Trial of Amrubicin for Treatment of Refractory or Relapsed Small-Cell Lung Cancer: Thoracic Oncology Research Group Study 0301
Onoda, S., Masuda, N., Seto, T., Eguchi, K., Takiguchi, Y., Isobe, H., Okamoto, H., Ogura, T., Yokoyama, A., Seki, N., Asaka-Amano, Y., Harada, M., Tagawa, A., Kunikane, H., Yokoba, M., Uematsu, K., KVolume:
24
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2006.08.4145
Date:
November, 2006
File:
PDF, 98 KB
english, 2006